Reverse Total Shoulder Arthroplasty study: Pectoralis Minor Release vs RSA
Official title Pectoralis Minor Release Versus Non-release in RSA
ClinicalTrials.gov ID: NCT06292169
What this study is testing
- What it's testing
- This study is testing whether cutting the pectoralis minor muscle during reverse shoulder arthroplasty improves pain relief, range of motion, and patient‑reported outcomes.
- Who it's for
- You may be able to join if you have reverse total shoulder arthroplasty, rotator cuff tear arthropathy, or advanced shoulder arthritis.
- What's involved
- You will have surgery with or without the muscle cut. After surgery you will have follow‑up visits and tests to check pain and movement.
- Time commitment
- The study lasts about a year, with several visits after surgery to track your progress.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All patients undergoing surgery for reverse total shoulder arthroplasty
- Patients willing and able to provide informed consent
You likely can't join if
- Revision arthroplasty
- Reverse shoulder arthroplasty for proximal humerus fractures
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.